| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/21/2009 | CN101347462A Health care composition for preventing osteoporosis |
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/21/2009 | CN100453530C Compounds and methods for inhibition of expression of VCAM-1 |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100453092C Use of a lupeol-rich extract to make a pharmaceutical or cosmetic composition for treating or preventing degeneration of dermal, cartilage and/or gingival connective tissue |
| 01/21/2009 | CN100453080C Lindera root alkaloid, its preparation method and application in medicine preparation |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
| 01/20/2009 | US7479495 N-heterocyclic inhibitors of TNF-α expression |
| 01/20/2009 | US7479478 Human parathyroid hormone modifications, preparation and use |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2392721C Intervertebral disc treatment devices and methods |
| 01/20/2009 | CA2383241C Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| 01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
| 01/20/2009 | CA2344411C 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2289880C A therapeutic agent for intractable vasculitis |
| 01/15/2009 | WO2009009122A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/15/2009 | WO2009008727A2 Molecules for targeting compounds to various selected organs or tissues |
| 01/15/2009 | WO2009008414A1 Monoclonal antibody having neutralizing activity against mmp13 |
| 01/15/2009 | WO2009007747A2 Hydantoin derivatives used as mmp12 inhibitors |
| 01/15/2009 | WO2009007697A1 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008135661A3 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 01/15/2009 | WO2008103318A3 The adipocyte secreted protein ccdc80 is a potent stimulator of bone formation |
| 01/15/2009 | WO2008099198A3 Osteogenic compounds |
| 01/15/2009 | WO2008064756A3 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 01/15/2009 | WO2008016404A3 Parathyroid hormone analogues and uses thereof |
| 01/15/2009 | WO2006003222A9 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018208 Novel Succinate Salt of O-Desmethyl-Venlafaxine |
| 01/15/2009 | US20090018185 Compositions and products containing s-equol, and methods for their making |
| 01/15/2009 | US20090018172 DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS OR BKCa CHANNEL MODULATORS |
| 01/15/2009 | US20090018167 angiogenesis inhibitors such as 1-phenyl-3-pyridin-2-ylprop-2-en-1-one, having antitumor and anticarcinogenic activity; treatment of skin disorders such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, and lymphangiogenesis, as well as chronic inflammatory disease such as arthritis |
| 01/15/2009 | US20090018158 Crystal forms of an imidazole derivative |
| 01/15/2009 | US20090018147 Compounds for modulating TRPV3 function |
| 01/15/2009 | US20090018137 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018128 Compounds |
| 01/15/2009 | US20090018121 Preventive and/or therapeutic agent for rheumatoid arthritis |
| 01/15/2009 | US20090018120 Amidine derivatives and their applications as a medicament |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090018069 Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2 |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018058 Vitamin D Receptor Modulators |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017145 Tri ascorbate formulation |
| 01/15/2009 | US20090017138 Topical medicament |
| 01/15/2009 | US20090017058 Viscosupplementation with algal polysaccharides in the treatment of arthritis |
| 01/15/2009 | US20090017043 Connective tissues growth factor antibodies |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017028 Antigen binding fragments (fab fragments) binds to a plurality of beta-chemokines; glomerulonephritis, scleroderrna, cirrhosis, multiple sclerosis, lupus nephritis, atherosclerosis, inflammatory bowel disease or rheumatoid arthritis; antiinflammatory agents |
| 01/15/2009 | US20090017018 Uses of mammalian cytokine: related reagents |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090017011 Modulation of vegf-c/vegfr-3 interactions in the treatment of rheumatoid arthritis |
| 01/15/2009 | CA2693048A1 Molecules for targeting compounds to various selected organs or tissues |
| 01/15/2009 | CA2692598A1 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/15/2009 | CA2692539A1 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin |
| 01/14/2009 | EP2014764A1 Method of producing dry yeast containing s-adenosyl-l-methionine and composition for oral intake |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014291A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 01/14/2009 | EP2014284A1 Pharmaceutical compositions and uses |
| 01/14/2009 | EP2013184A1 Sulfonamide compounds useful as edg receptor modulators |
| 01/14/2009 | EP1844050B1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 01/14/2009 | EP1549741B1 Novel endothelial cells, antibodies against said cells and use thereof |
| 01/14/2009 | EP1466900B1 2-substituted vitamin d derivatives |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1406678B1 Drug delivery matrices to enhance wound healing |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1311241B1 Use of a porous carrier |
| 01/14/2009 | EP1307541B1 Tissue implant for cartilage repair |
| 01/14/2009 | EP1283057B1 Cell proliferation inhibitors |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343299A Lxeris sonchifolia(bunge)hance flavone extract, preparation method and application thereof |
| 01/14/2009 | CN101343294A Preparation method for sulphuric acid glucosamine |
| 01/14/2009 | CN101342342A Medicament for treating dorsal disc prolapse |
| 01/14/2009 | CN101342295A Traditional Chinese medicine ointment for treating arthrosis and preparation method |
| 01/14/2009 | CN101342290A Tong bi liquid and preparation method thereof |
| 01/14/2009 | CN101342289A Pill for treating cold bone paralysis |
| 01/14/2009 | CN101342287A Medical ointment for quickly knitting bone, relaxing tendons, and activating blood circulation, removing stasis, and preparation method thereof |
| 01/14/2009 | CN101342286A Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny |
| 01/14/2009 | CN101342279A Liquid for expelling wind, dissipating cold and relaxing vein, and preparation method thereof |
| 01/14/2009 | CN101342278A Bone regeneration treating pellet and preparation method thereof |
| 01/14/2009 | CN101342244A Traditional Chinese medicine bone setting powder for treating rheumatism bone disease based on hot-salt method |
| 01/14/2009 | CN101342228A Quick-effective bone-knitting medicament |
| 01/14/2009 | CN101342206A Tonglibaihui formulation for treating traumatic injury |
| 01/14/2009 | CN101341979A Health beverage and preparation method |
| 01/14/2009 | CN100450544C Compound medicinal preparation for treating femur necrosis |
| 01/14/2009 | CN100450535C Chinese medicine for treating lumhardisc protrusion |
| 01/14/2009 | CN100450533C Traditional Chinese medicine for treating femoral head necrosis |
| 01/14/2009 | CN100450512C Chinese medicine neck support for treating cervix vertebra disease and its preparing method |
| 01/14/2009 | CN100450502C Active extract of lamtophlomis rotata and its preparing method and use |
| 01/14/2009 | CN100450494C Medicinal use of Aralia continentalis kitag |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |